United States Biotechnology & Medical Research

ARIAD Pharmaceuticals Inc (ARIA)

Track

Track

Ticker: ARIA Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Bollag Daniel M Sr. VP, Reg. Affairs & Quality
Transaction date
Planned sale
Price
312.66
Quantity 59,861 -5.4%
Value US$3,338,807
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Planned sale
Price
364.88
Quantity 16,122 +8.0%
Value US$3,222,163
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Officer
Transaction date
Planned sale
Price
450.82
Quantity 82,427 -43.3%
Value US$3,171,823
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Planned sale
Price
13.98
Quantity 8,750 -3.9%
Value US$122,311
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Planned sale
Price
13.43
Quantity 20,000 -8.7%
Value US$268,536
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Planned sale
Price
11.73
Quantity 59,369 -20.6%
Value US$696,398
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Planned sale
Price
10.47
Quantity 19,436 -7.8%
Value US$203,538
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Planned sale
Price
10.50
Quantity 25,000 -9.2%
Value US$262,500
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Planned sale
Price
8.11
Quantity 18,286 -6.9%
Value US$148,230
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Planned sale
Price
7.48
Quantity 30,000 -10.1%
Value US$224,481
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Planned sale
Price
7.48
Quantity 31,422 -10.5%
Value US$235,153
Cole Hugh M SVP, Chief Business Officer Officer
Transaction date
Sale
Price
7.05
Quantity 6,012 -16.7%
Value US$42,385
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Planned sale
Price
7.28
Quantity 23,999 -8.3%
Value US$174,638
LAVIDAS ATHANESE Non-Executive Director
Transaction date
Sale
Price
8.24
Quantity 46,250 -26.0%
Value US$381,137
LAVIDAS ATHANESE Non-Executive Director
Transaction date
Sale
Price
8.14
Quantity 20,000 -13.2%
Value US$162,852
Radaelli Massimo Non-Executive Director
Transaction date
Sale
Price
8.13
Quantity 6,250 -5.6%
Value US$50,834
LAVIDAS ATHANESE Non-Executive Director
Transaction date
Sale
Price
8.21
Quantity 10,000 -7.1%
Value US$82,050
Radaelli Massimo Non-Executive Director
Transaction date
Sale
Price
8.25
Quantity 79,731 -43.0%
Value US$657,821
Radaelli Massimo Non-Executive Director
Transaction date
Sale
Price
8.30
Quantity 22,588 -17.6%
Value US$187,480
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Planned sale
Price
8.08
Quantity 17,762 -5.8%
Value US$143,430
Panayiotopoulos Paris President and CEO Executive Director
Transaction date
Purchase
Price
7.41
Quantity 26,990 +44.2%
Value US$199,996
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Planned sale
Price
7.13
Quantity 11,700 -3.7%
Value US$83,478
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Planned sale
Price
7.37
Quantity 21,409 -6.8%
Value US$157,864
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Planned sale
Price
6.58
Quantity 23,834 -7.0%
Value US$156,871
Haluska Frank SVP, Clinical R&D, CMO Officer
Transaction date
Planned sale
Price
6.47
Quantity 3,575 -2.4%
Value US$23,116
FITZGERALD EDWARD M Executive VP Officer
Transaction date
Planned sale
Price
6.47
Quantity 5,417 -1.7%
Value US$35,037
BERSTEIN DAVID L SVP, Chief IP Counsel Officer
Transaction date
Planned sale
Price
6.47
Quantity 2,375 -0.9%
Value US$15,356
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Officer
Transaction date
Planned sale
Price
6.47
Quantity 4,000 -2.5%
Value US$25,871
Duvall Martin J EVP, CCO Officer
Transaction date
Planned sale
Price
6.47
Quantity 4,000 -4.1%
Value US$25,867
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Planned sale
Price
6.47
Quantity 5,417 -1.6%
Value US$35,039
Cantor Maria E SVP, Corporate Affairs Officer
Transaction date
Planned sale
Price
6.46
Quantity 3,575 -2.6%
Value US$23,102
Duvall Martin J EVP, CCO Officer
Transaction date
Planned sale
Price
6.12
Quantity 9,625 -9.8%
Value US$58,863
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Officer
Transaction date
Planned sale
Price
6.11
Quantity 9,625 -6.0%
Value US$58,852
Cantor Maria E SVP, Corporate Affairs Officer
Transaction date
Planned sale
Price
6.12
Quantity 9,625 -6.8%
Value US$58,869
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Planned sale
Price
6.12
Quantity 9,625 -2.8%
Value US$58,867
FITZGERALD EDWARD M Executive VP, CFO Officer
Transaction date
Planned sale
Price
6.12
Quantity 9,625 -3.0%
Value US$58,866
Haluska Frank SVP, Clinical R&D, CMO Officer
Transaction date
Planned sale
Price
6.11
Quantity 10,588 -6.8%
Value US$64,733
BERSTEIN DAVID L SVP, Chief IP Counsel Officer
Transaction date
Planned sale
Price
6.12
Quantity 9,625 -3.6%
Value US$58,887
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Sale
Price
6.00
Quantity 25,047 -6.8%
Value US$150,282
Haluska Frank SVP, Clinical R&D, CMO Officer
Transaction date
Planned sale
Price
4.81
Quantity 16,133 -10.6%
Value US$77,587
Cantor Maria E SVP, Corporate Affairs Officer
Transaction date
Planned sale
Price
4.81
Quantity 14,667 -10.6%
Value US$70,517
Cantor Maria E SVP, Corporate Affairs Officer
Transaction date
Planned sale
Price
4.93
Quantity 1,466 -1.1%
Value US$7,227
Duvall Martin J EVP, CCO Officer
Transaction date
Planned sale
Price
4.81
Quantity 14,667 -15.6%
Value US$70,578
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Planned sale
Price
4.81
Quantity 14,667 -4.0%
Value US$70,517
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Officer
Transaction date
Planned sale
Price
4.81
Quantity 14,667 -9.4%
Value US$70,548
BERSTEIN DAVID L SVP, Chief IP Counsel Officer
Transaction date
Planned sale
Price
4.81
Quantity 14,667 -5.5%
Value US$70,515
FITZGERALD EDWARD M Executive VP, CFO Officer
Transaction date
Planned sale
Price
4.81
Quantity 14,667 -4.6%
Value US$70,515
Panayiotopoulos Paris President and CEO Executive Director
Transaction date
Purchase
Price
4.91
Quantity 61,099 +inf%
Value US$299,996
Cantor Maria E SVP, Corporate Affairs Officer
Transaction date
Planned sale
Price
6.47
Quantity 5,000 -4.4%
Value US$32,326
FITZGERALD EDWARD M Executive VP, CFO Officer
Transaction date
Planned sale
Price
6.46
Quantity 8,750 -2.9%
Value US$56,551
BERSTEIN DAVID L SVP, Chief IP Counsel Officer
Transaction date
Planned sale
Price
6.46
Quantity 5,000 -2.0%
Value US$32,316
Duvall Martin J EVP, CCO Officer
Transaction date
Planned sale
Price
6.46
Quantity 5,000 -7.2%
Value US$32,316
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Officer
Transaction date
Sale
Price
6.46
Quantity 5,000 -3.8%
Value US$32,316
Haluska Frank SVP, Clinical R&D, CMO Officer
Transaction date
Planned sale
Price
6.46
Quantity 5,500 -4.3%
Value US$35,502
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Planned sale
Price
6.46
Quantity 8,750 -2.6%
Value US$56,560
Haluska Frank SVP, Clinical R&D, CMO Officer
Transaction date
Planned sale
Price
8.54
Quantity 4,400 -3.6%
Value US$37,575
Duvall Martin J EVP, CCO Officer
Transaction date
Planned sale
Price
8.54
Quantity 1,400 -2.3%
Value US$11,956
FITZGERALD EDWARD M Executive VP, CFO Officer
Transaction date
Planned sale
Price
8.54
Quantity 7,000 -2.2%
Value US$59,793
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Planned sale
Price
8.54
Quantity 7,000 -2.1%
Value US$59,797
Cantor Maria E SVP, Corporate Affairs Officer
Transaction date
Planned sale
Price
8.54
Quantity 4,000 -3.5%
Value US$34,162
BERSTEIN DAVID L SVP, Chief IP Counsel Officer
Transaction date
Planned sale
Price
8.54
Quantity 4,000 -1.7%
Value US$34,162
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Officer
Transaction date
Planned sale
Price
8.54
Quantity 4,000 -3.2%
Value US$34,164
FITZGERALD EDWARD M Executive VP, CFO Officer
Transaction date
Planned sale
Price
8.80
Quantity 60,000 -16.4%
Value US$528,000
BERSTEIN DAVID L SVP, Chief IP Counsel Officer
Transaction date
Planned sale
Price
8.56
Quantity 2,000 -1.2%
Value US$17,118
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Officer
Transaction date
Planned sale
Price
8.55
Quantity 3,000 -2.5%
Value US$25,660
FITZGERALD EDWARD M Executive VP, CFO Officer
Transaction date
Planned sale
Price
8.55
Quantity 4,167 -1.3%
Value US$35,630
Duvall Martin J EVP, CCO Officer
Transaction date
Planned sale
Price
8.57
Quantity 834 -1.5%
Value US$7,145
Haluska Frank SVP, Clinical R&D, CMO Officer
Transaction date
Planned sale
Price
8.55
Quantity 3,300 -2.8%
Value US$28,229
Cantor Maria E SVP, Corporate Affairs and HR Officer
Transaction date
Planned sale
Price
8.55
Quantity 4,033 -3.7%
Value US$34,491
CLACKSON TIMOTHY P President, R&D, CSO Officer
Transaction date
Planned sale
Price
8.55
Quantity 6,667 -1.5%
Value US$57,016
BERSTEIN DAVID L SVP, Chief IP Counsel Officer
Transaction date
Planned sale
Price
8.85
Quantity 2,375 -1.5%
Value US$21,026
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Officer
Transaction date
Planned sale
Price
8.85
Quantity 4,000 -3.4%
Value US$35,390
FITZGERALD EDWARD M Executive VP, CFO Officer
Transaction date
Planned sale
Price
8.84
Quantity 5,417 -1.8%
Value US$47,908
Duvall Martin J EVP, CCO Officer
Transaction date
Planned sale
Price
8.85
Quantity 4,000 -6.9%
Value US$35,381
Haluska Frank SVP, Clinical R&D, CMO Officer
Transaction date
Planned sale
Price
8.85
Quantity 3,575 -3.1%
Value US$31,634
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2017-01-10 2017-01-09 PlS Planned sale Bollag Daniel M

Sr. VP, Reg. Affairs & Quality
59,861 -5.4%
312.66
US$3,338,807 		59,861 -5.4% 312.66 US$3,338,807
2016-10-25 2016-10-24 PlS Planned sale
CLACKSON TIMOTHY P

President, R&D, CSO

Officer
16,122 +8.0%
364.88
US$3,222,163 		16,122 +8.0% 364.88 US$3,222,163
2016-10-05 2016-10-03 PlS Planned sale Bollag Daniel M

Sr. VP, Reg. Affairs & Quality

Officer
82,427 -43.3%
450.82
US$3,171,823 		82,427 -43.3% 450.82 US$3,171,823
2016-09-28 2016-09-28 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
8,750 -3.9%
13.98
US$122,311 		8,750 -3.9% 13.98 US$122,311
2016-09-23 2016-09-22 PlS Planned sale
CLACKSON TIMOTHY P

President, R&D, CSO

Officer
20,000 -8.7%
13.43
US$268,536 		20,000 -8.7% 13.43 US$268,536
2016-09-16 2016-09-15 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
59,369 -20.6%
11.73
US$696,398 		59,369 -20.6% 11.73 US$696,398
2016-08-23 2016-08-22 PlS Planned sale
CLACKSON TIMOTHY P

President, R&D, CSO

Officer
19,436 -7.8%
10.47
US$203,538 		19,436 -7.8% 10.47 US$203,538
2016-08-15 2016-08-12 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
25,000 -9.2%
10.50
US$262,500 		25,000 -9.2% 10.50 US$262,500
2016-07-25 2016-07-22 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
18,286 -6.9%
8.11
US$148,230 		18,286 -6.9% 8.11 US$148,230
2016-07-05 2016-07-01 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
30,000 -10.1%
7.48
US$224,481 		30,000 -10.1% 7.48 US$224,481
2016-07-05 2016-07-01 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
31,422 -10.5%
7.48
US$235,153 		31,422 -10.5% 7.48 US$235,153
2016-06-29 2016-06-28 S Sale Cole Hugh M

SVP, Chief Business Officer

Officer
6,012 -16.7%
7.05
US$42,385 		6,012 -16.7% 7.05 US$42,385
2016-06-23 2016-06-22 PlS Planned sale
CLACKSON TIMOTHY P

President, R&D, CSO

Officer
23,999 -8.3%
7.28
US$174,638 		23,999 -8.3% 7.28 US$174,638
2016-06-15 2016-06-15 S Sale LAVIDAS ATHANESE Non-Executive Director
46,250 -26.0%
8.24
US$381,137 		46,250 -26.0% 8.24 US$381,137
2016-06-15 2016-06-14 S Sale LAVIDAS ATHANESE Non-Executive Director
20,000 -13.2%
8.14
US$162,852 		20,000 -13.2% 8.14 US$162,852
2016-06-14 2016-06-14 S Sale Radaelli Massimo Non-Executive Director
6,250 -5.6%
8.13
US$50,834 		6,250 -5.6% 8.13 US$50,834
2016-06-15 2016-06-13 S Sale LAVIDAS ATHANESE Non-Executive Director
10,000 -7.1%
8.21
US$82,050 		10,000 -7.1% 8.21 US$82,050
2016-06-14 2016-06-13 S Sale Radaelli Massimo Non-Executive Director
79,731 -43.0%
8.25
US$657,821 		79,731 -43.0% 8.25 US$657,821
2016-06-14 2016-06-10 S Sale Radaelli Massimo Non-Executive Director
22,588 -17.6%
8.30
US$187,480 		22,588 -17.6% 8.30 US$187,480
2016-05-25 2016-05-23 PlS Planned sale
CLACKSON TIMOTHY P

President, R&D, CSO

Officer
17,762 -5.8%
8.08
US$143,430 		17,762 -5.8% 8.08 US$143,430
2016-05-13 2016-05-12 B Purchase Panayiotopoulos Paris

President and CEO

Executive Director
26,990 +44.2%
7.41
US$199,996 		26,990 +44.2% 7.41 US$199,996
2016-05-02 2016-05-02 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
11,700 -3.7%
7.13
US$83,478 		11,700 -3.7% 7.13 US$83,478
2016-04-25 2016-04-22 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
21,409 -6.8%
7.37
US$157,864 		21,409 -6.8% 7.37 US$157,864
2016-03-23 2016-03-22 PlS Planned sale
CLACKSON TIMOTHY P

President, R&D, CSO

Officer
23,834 -7.0%
6.58
US$156,871 		23,834 -7.0% 6.58 US$156,871
2016-03-22 2016-03-21 PlS Planned sale Haluska Frank

SVP, Clinical R&D, CMO

Officer
3,575 -2.4%
6.47
US$23,116 		3,575 -2.4% 6.47 US$23,116
2016-03-22 2016-03-21 PlS Planned sale FITZGERALD EDWARD M

Executive VP

Officer
5,417 -1.7%
6.47
US$35,037 		5,417 -1.7% 6.47 US$35,037
2016-03-22 2016-03-21 PlS Planned sale BERSTEIN DAVID L

SVP, Chief IP Counsel

Officer
2,375 -0.9%
6.47
US$15,356 		2,375 -0.9% 6.47 US$15,356
2016-03-22 2016-03-21 PlS Planned sale Bollag Daniel M

Sr. VP, Reg. Affairs & Quality

Officer
4,000 -2.5%
6.47
US$25,871 		4,000 -2.5% 6.47 US$25,871
2016-03-22 2016-03-19 PlS Planned sale Duvall Martin J

EVP, CCO

Officer
4,000 -4.1%
6.47
US$25,867 		4,000 -4.1% 6.47 US$25,867
2016-03-22 2016-03-19 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
5,417 -1.6%
6.47
US$35,039 		5,417 -1.6% 6.47 US$35,039
2016-03-22 2016-03-19 PlS Planned sale Cantor Maria E

SVP, Corporate Affairs

Officer
3,575 -2.6%
6.46
US$23,102 		3,575 -2.6% 6.46 US$23,102
2016-03-03 2016-03-03 PlS Planned sale Duvall Martin J

EVP, CCO

Officer
9,625 -9.8%
6.12
US$58,863 		9,625 -9.8% 6.12 US$58,863
2016-03-03 2016-03-03 PlS Planned sale Bollag Daniel M

Sr. VP, Reg. Affairs & Quality

Officer
9,625 -6.0%
6.11
US$58,852 		9,625 -6.0% 6.11 US$58,852
2016-03-03 2016-03-03 PlS Planned sale Cantor Maria E

SVP, Corporate Affairs

Officer
9,625 -6.8%
6.12
US$58,869 		9,625 -6.8% 6.12 US$58,869
2016-03-03 2016-03-03 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
9,625 -2.8%
6.12
US$58,867 		9,625 -2.8% 6.12 US$58,867
2016-03-03 2016-03-03 PlS Planned sale FITZGERALD EDWARD M

Executive VP, CFO

Officer
9,625 -3.0%
6.12
US$58,866 		9,625 -3.0% 6.12 US$58,866
2016-03-03 2016-03-03 PlS Planned sale Haluska Frank

SVP, Clinical R&D, CMO

Officer
10,588 -6.8%
6.11
US$64,733 		10,588 -6.8% 6.11 US$64,733
2016-03-03 2016-03-03 PlS Planned sale BERSTEIN DAVID L

SVP, Chief IP Counsel

Officer
9,625 -3.6%
6.12
US$58,887 		9,625 -3.6% 6.12 US$58,887
2016-03-03 2016-03-02 S Sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
25,047 -6.8%
6.00
US$150,282 		25,047 -6.8% 6.00 US$150,282
2016-02-03 2016-02-01 PlS Planned sale Haluska Frank

SVP, Clinical R&D, CMO

Officer
16,133 -10.6%
4.81
US$77,587 		16,133 -10.6% 4.81 US$77,587
2016-02-03 2016-02-01 PlS Planned sale Cantor Maria E

SVP, Corporate Affairs

Officer
14,667 -10.6%
4.81
US$70,517 		14,667 -10.6% 4.81 US$70,517
2016-02-03 2016-02-01 PlS Planned sale Cantor Maria E

SVP, Corporate Affairs

Officer
1,466 -1.1%
4.93
US$7,227 		1,466 -1.1% 4.93 US$7,227
2016-02-03 2016-02-01 PlS Planned sale Duvall Martin J

EVP, CCO

Officer
14,667 -15.6%
4.81
US$70,578 		14,667 -15.6% 4.81 US$70,578
2016-02-03 2016-02-01 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
14,667 -4.0%
4.81
US$70,517 		14,667 -4.0% 4.81 US$70,517
2016-02-03 2016-02-01 PlS Planned sale Bollag Daniel M

Sr. VP, Reg. Affairs & Quality

Officer
14,667 -9.4%
4.81
US$70,548 		14,667 -9.4% 4.81 US$70,548
2016-02-03 2016-02-01 PlS Planned sale BERSTEIN DAVID L

SVP, Chief IP Counsel

Officer
14,667 -5.5%
4.81
US$70,515 		14,667 -5.5% 4.81 US$70,515
2016-02-03 2016-02-01 PlS Planned sale FITZGERALD EDWARD M

Executive VP, CFO

Officer
14,667 -4.6%
4.81
US$70,515 		14,667 -4.6% 4.81 US$70,515
2016-02-03 2016-02-01 B Purchase Panayiotopoulos Paris

President and CEO

Executive Director
61,099 +inf%
4.91
US$299,996 		61,099 +inf% 4.91 US$299,996
2015-09-28 2015-09-28 PlS Planned sale Cantor Maria E

SVP, Corporate Affairs

Officer
5,000 -4.4%
6.47
US$32,326 		5,000 -4.4% 6.47 US$32,326
2015-09-28 2015-09-28 PlS Planned sale FITZGERALD EDWARD M

Executive VP, CFO

Officer
8,750 -2.9%
6.46
US$56,551 		8,750 -2.9% 6.46 US$56,551
2015-09-28 2015-09-28 PlS Planned sale BERSTEIN DAVID L

SVP, Chief IP Counsel

Officer
5,000 -2.0%
6.46
US$32,316 		5,000 -2.0% 6.46 US$32,316
2015-09-28 2015-09-28 PlS Planned sale Duvall Martin J

EVP, CCO

Officer
5,000 -7.2%
6.46
US$32,316 		5,000 -7.2% 6.46 US$32,316
2015-09-28 2015-09-28 S Sale Bollag Daniel M

Sr. VP, Reg. Affairs & Quality

Officer
5,000 -3.8%
6.46
US$32,316 		5,000 -3.8% 6.46 US$32,316
2015-09-28 2015-09-28 PlS Planned sale Haluska Frank

SVP, Clinical R&D, CMO

Officer
5,500 -4.3%
6.46
US$35,502 		5,500 -4.3% 6.46 US$35,502
2015-09-28 2015-09-28 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
8,750 -2.6%
6.46
US$56,560 		8,750 -2.6% 6.46 US$56,560
2015-07-16 2015-07-16 PlS Planned sale Haluska Frank

SVP, Clinical R&D, CMO

Officer
4,400 -3.6%
8.54
US$37,575 		4,400 -3.6% 8.54 US$37,575
2015-07-16 2015-07-16 PlS Planned sale Duvall Martin J

EVP, CCO

Officer
1,400 -2.3%
8.54
US$11,956 		1,400 -2.3% 8.54 US$11,956
2015-07-16 2015-07-16 PlS Planned sale FITZGERALD EDWARD M

Executive VP, CFO

Officer
7,000 -2.2%
8.54
US$59,793 		7,000 -2.2% 8.54 US$59,793
2015-07-16 2015-07-16 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
7,000 -2.1%
8.54
US$59,797 		7,000 -2.1% 8.54 US$59,797
2015-07-16 2015-07-16 PlS Planned sale Cantor Maria E

SVP, Corporate Affairs

Officer
4,000 -3.5%
8.54
US$34,162 		4,000 -3.5% 8.54 US$34,162
2015-07-16 2015-07-16 PlS Planned sale BERSTEIN DAVID L

SVP, Chief IP Counsel

Officer
4,000 -1.7%
8.54
US$34,162 		4,000 -1.7% 8.54 US$34,162
2015-07-16 2015-07-16 PlS Planned sale Bollag Daniel M

Sr. VP, Reg. Affairs & Quality

Officer
4,000 -3.2%
8.54
US$34,164 		4,000 -3.2% 8.54 US$34,164
2015-05-04 2015-05-01 PlS Planned sale FITZGERALD EDWARD M

Executive VP, CFO

Officer
60,000 -16.4%
8.80
US$528,000 		60,000 -16.4% 8.80 US$528,000
2015-03-23 2015-03-23 PlS Planned sale BERSTEIN DAVID L

SVP, Chief IP Counsel

Officer
2,000 -1.2%
8.56
US$17,118 		2,000 -1.2% 8.56 US$17,118
2015-03-23 2015-03-23 PlS Planned sale Bollag Daniel M

Sr. VP, Reg. Affairs & Quality

Officer
3,000 -2.5%
8.55
US$25,660 		3,000 -2.5% 8.55 US$25,660
2015-03-23 2015-03-23 PlS Planned sale FITZGERALD EDWARD M

Executive VP, CFO

Officer
4,167 -1.3%
8.55
US$35,630 		4,167 -1.3% 8.55 US$35,630
2015-03-23 2015-03-23 PlS Planned sale Duvall Martin J

EVP, CCO

Officer
834 -1.5%
8.57
US$7,145 		834 -1.5% 8.57 US$7,145
2015-03-23 2015-03-23 PlS Planned sale Haluska Frank

SVP, Clinical R&D, CMO

Officer
3,300 -2.8%
8.55
US$28,229 		3,300 -2.8% 8.55 US$28,229
2015-03-23 2015-03-23 PlS Planned sale Cantor Maria E

SVP, Corporate Affairs and HR

Officer
4,033 -3.7%
8.55
US$34,491 		4,033 -3.7% 8.55 US$34,491
2015-03-23 2015-03-23 PlS Planned sale CLACKSON TIMOTHY P

President, R&D, CSO

Officer
6,667 -1.5%
8.55
US$57,016 		6,667 -1.5% 8.55 US$57,016
2015-03-23 2015-03-20 PlS Planned sale BERSTEIN DAVID L

SVP, Chief IP Counsel

Officer
2,375 -1.5%
8.85
US$21,026 		2,375 -1.5% 8.85 US$21,026
2015-03-23 2015-03-20 PlS Planned sale Bollag Daniel M

Sr. VP, Reg. Affairs & Quality

Officer
4,000 -3.4%
8.85
US$35,390 		4,000 -3.4% 8.85 US$35,390
2015-03-23 2015-03-20 PlS Planned sale FITZGERALD EDWARD M

Executive VP, CFO

Officer
5,417 -1.8%
8.84
US$47,908 		5,417 -1.8% 8.84 US$47,908
2015-03-23 2015-03-20 PlS Planned sale Duvall Martin J

EVP, CCO

Officer
4,000 -6.9%
8.85
US$35,381 		4,000 -6.9% 8.85 US$35,381
2015-03-23 2015-03-20 PlS Planned sale Haluska Frank

SVP, Clinical R&D, CMO

Officer
3,575 -3.1%
8.85
US$31,634 		3,575 -3.1% 8.85 US$31,634
Explore more

More insider trading research around ARIAD Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America